• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response.关于：羟氯喹啉联合或不联合阿奇霉素对新冠病毒疾病患者死亡率的影响：作者回应
Clin Microbiol Infect. 2021 Jun;27(6):920-921. doi: 10.1016/j.cmi.2020.10.031. Epub 2020 Nov 6.
2
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.羟氯喹啉联合或不联合阿奇霉素对COVID-19患者死亡率的影响：作者回应
Clin Microbiol Infect. 2021 Jan;27(1):138-140. doi: 10.1016/j.cmi.2020.10.002. Epub 2020 Oct 17.
3
Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.关于：菲奥莱特等人的《羟氯喹联合或不联合阿奇霉素对COVID-19患者死亡率的影响：系统评价与荟萃分析》
Clin Microbiol Infect. 2021 Jun;27(6):918-919. doi: 10.1016/j.cmi.2020.10.018. Epub 2020 Oct 28.
4
Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann.羟氯喹和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒清除的影响：对埃尔韦·塞利格曼的回应
Int J Antimicrob Agents. 2021 Mar;57(3):106306. doi: 10.1016/j.ijantimicag.2021.106306. Epub 2021 Feb 14.
5
Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.羟氯喹、阿奇霉素和环索奈德三联疗法治疗 COVID-19 肺炎。
J Microbiol Immunol Infect. 2021 Feb;54(1):109-112. doi: 10.1016/j.jmii.2020.09.003. Epub 2020 Oct 5.
6
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.羟氯喹、阿奇霉素和联合治疗 COVID-19 住院患者。
Int J Infect Dis. 2020 Aug;97:396-403. doi: 10.1016/j.ijid.2020.06.099. Epub 2020 Jul 2.
7
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.羟氯喹联合或不联合阿奇霉素对 COVID-19 患者死亡率的影响：系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Jan;27(1):19-27. doi: 10.1016/j.cmi.2020.08.022. Epub 2020 Aug 26.
8
Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.羟氯喹和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒载量的影响尚不确定。
Int J Antimicrob Agents. 2021 Jan;57(1):106169. doi: 10.1016/j.ijantimicag.2020.106169.
9
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.纽约州 COVID-19 患者住院死亡率与羟氯喹或阿奇霉素治疗的关联。
JAMA. 2020 Jun 23;323(24):2493-2502. doi: 10.1001/jama.2020.8630.
10
Hydroxychloroquine + azithromycin treatment in elderly patients.老年患者的羟氯喹啉 + 阿奇霉素治疗
Int J Antimicrob Agents. 2021 Apr;57(4):106313. doi: 10.1016/j.ijantimicag.2021.106313. Epub 2021 Mar 11.

引用本文的文献

1
Inhibition of Autophagy Suppresses SARS-CoV-2 Replication and Ameliorates Pneumonia in hACE2 Transgenic Mice and Xenografted Human Lung Tissues.自噬抑制可抑制 SARS-CoV-2 复制并改善 hACE2 转基因小鼠和异种移植人肺组织中的肺炎。
J Virol. 2021 Nov 23;95(24):e0153721. doi: 10.1128/JVI.01537-21. Epub 2021 Sep 22.
2
Difficult editorial decisions.艰难的编辑决策。
Clin Microbiol Infect. 2021 Jan;27(1):1-2. doi: 10.1016/j.cmi.2020.10.013. Epub 2020 Oct 27.
3
Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study.精神障碍与羟氯喹治疗 2019 年冠状病毒病（COVID-19）：一项 VigiBase 研究。
Drug Saf. 2020 Dec;43(12):1315-1322. doi: 10.1007/s40264-020-01013-3. Epub 2020 Oct 19.

本文引用的文献

1
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.羟氯喹和氯喹治疗 COVID-19 的国际合作随机试验荟萃分析的死亡率结果。
Nat Commun. 2021 Apr 15;12(1):2349. doi: 10.1038/s41467-021-22446-z.
2
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.用于治疗新冠肺炎的抗病毒药物 repurposed - 世界卫生组织团结试验中期结果
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
3
Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.羟氯喹啉联合或不联合阿奇霉素对COVID-19患者死亡率的影响：作者回应
Clin Microbiol Infect. 2021 Jan;27(1):138-140. doi: 10.1016/j.cmi.2020.10.002. Epub 2020 Oct 17.
4
Time to Reassess Tocilizumab's Role in COVID-19 Pneumonia.重新评估托珠单抗在新冠肺炎肺炎中作用的时机
JAMA Intern Med. 2021 Jan 1;181(1):12-15. doi: 10.1001/jamainternmed.2020.6557.
5
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8.
6
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis.氯喹或羟氯喹治疗 COVID-19 患者的疗效：系统评价和荟萃分析。
J Antimicrob Chemother. 2021 Jan 1;76(1):30-42. doi: 10.1093/jac/dkaa403.
7
Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).干预治疗 COVID-19：一项具有荟萃分析和试验序贯分析的实时系统评价（LIVING 项目）。
PLoS Med. 2020 Sep 17;17(9):e1003293. doi: 10.1371/journal.pmed.1003293. eCollection 2020 Sep.
8
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.羟氯喹联合或不联合阿奇霉素对 COVID-19 患者死亡率的影响：系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Jan;27(1):19-27. doi: 10.1016/j.cmi.2020.08.022. Epub 2020 Aug 26.
9
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19.羟氯喹在美国 COVID-19 住院患者中的使用效果。
Med. 2020 Dec 18;1(1):114-127.e3. doi: 10.1016/j.medj.2020.06.001. Epub 2020 Jun 5.
10
Comment on Arshad et al.: Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19.对阿尔沙德等人的评论：新冠病毒肺炎住院患者使用羟氯喹、阿奇霉素及联合用药治疗。
Int J Infect Dis. 2020 Oct;99:373. doi: 10.1016/j.ijid.2020.07.071. Epub 2020 Aug 6.

Re: effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: author's response.

作者信息

Fiolet Thibault, Guihur Anthony, Rebeaud Mathieu Edouard, Mulot Matthieu, Peiffer-Smadja Nathan, Mahamat-Saleh Yahya

机构信息

CESP (Center for Research in Epidemiology and Population Health), Fac. de Médecine - Univ. Paris-Sud, Fac. de Médecine - UVSQ, INSERM, Université Paris Saclay, Villejuif, France; Gustave Roussy, Villejuif, France.

Department of Plant Molecular Biology, Faculty of Biology and Medicine, University of Lausanne, Switzerland.

出版信息

Clin Microbiol Infect. 2021 Jun;27(6):920-921. doi: 10.1016/j.cmi.2020.10.031. Epub 2020 Nov 6.

DOI:10.1016/j.cmi.2020.10.031
PMID:33166647
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7647442/
Abstract
摘要